Hazlett, Burt & Watson’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-189
Closed -$4K – 924
2026
Q1
$4K Buy
189
+1
+0.5% +$21 ﹤0.01% 794
2025
Q4
$4K Buy
188
+3
+2% +$64 ﹤0.01% 801
2025
Q3
$4K Buy
+185
New +$3.9K ﹤0.01% 751

Other funds holding IBDW

Hazlett, Burt & Watson's IBDW Position: Q2 2026 in Review

Hazlett, Burt & Watson sold out of iShares iBonds Dec 2031 Term Corporate ETF (IBDW) in Q2 2026, closing a stake of 189 shares — an estimated $4K sold.

Hazlett, Burt & Watson first reported a position in IBDW in Q3 2025 and held it in 3 quarters. The position peaked at $4K in Q1 2026. 293 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Hazlett, Burt & Watson reported no remaining iShares iBonds Dec 2031 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 189 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $4K.
  • Hazlett, Burt & Watson first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q3 2025 and held it in 3 quarters.
  • Hazlett, Burt & Watson's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $4K in Q1 2026.
  • 293 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.